These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8449204)

  • 1. Cibenzoline transforms random re-entry into ordered re-entry in the atria.
    Brugada J; Gürsoy S; Brugada P; Atié J; Guiraudon G; Andries E
    Eur Heart J; 1993 Feb; 14(2):267-72. PubMed ID: 8449204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of cibenzoline on atrial vulnerability and value of electrophysiological methods in the treatment of paroxysmal atrial fibrillation].
    Kühlkamp V; Ickrath O; Seipel L
    Z Kardiol; 1990 Aug; 79(8):541-6. PubMed ID: 2220012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiologic effects and efficacy of cibenzoline on stimulation-induced atrial fibrillation and flutter and implications for treatment of paroxysmal atrial fibrillation.
    Kühlkamp V; Meerhof J; Schmidt F; Mayer F; Ickrath O; Haasis R; Seipel L
    Am J Cardiol; 1990 Mar; 65(9):628-32. PubMed ID: 2309633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Widening of the excitable gap during pharmacological cardioversion of atrial fibrillation in the goat: effects of cibenzoline, hydroquinidine, flecainide, and d-sotalol.
    Wijffels MC; Dorland R; Mast F; Allessie MA
    Circulation; 2000 Jul; 102(2):260-7. PubMed ID: 10889140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serial cardioversion by class IC Drugs during 4 months of persistent atrial fibrillation in the goat.
    Eijsbouts S; Ausma J; Blaauw Y; Schotten U; Duytschaever M; Allessie MA
    J Cardiovasc Electrophysiol; 2006 Jun; 17(6):648-54. PubMed ID: 16836716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrophysiologic effects of a class I antiarrhythmic agent, cibenzoline, on the refractoriness and conduction of the human atrium in vivo.
    Esato M; Shimizu A; Chun YH; Tatsuno H; Yamagata T; Matsuzaki M
    J Cardiovasc Pharmacol; 1996 Aug; 28(2):321-7. PubMed ID: 8856490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fractionation of electrograms and linking of activation during pharmacologic cardioversion of persistent atrial fibrillation in the goat.
    Shan Z; Van Der Voort PH; Blaauw Y; Duytschaever M; Allessie MA
    J Cardiovasc Electrophysiol; 2004 May; 15(5):572-80. PubMed ID: 15149428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decrease in the spatial dispersion at the termination of atrial fibrillation by intravenous cibenzoline.
    Kakugawa H; Shimizu A; Yamagata T; Esato M; Ueyama T; Yoshiga Y; Kanemoto M; Matsuzaki M
    Circ J; 2003 Oct; 67(10):810-5. PubMed ID: 14578610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic cardioversion of chronic atrial fibrillation in the goat by class IA, IC, and III drugs: a comparison between hydroquinidine, cibenzoline, flecainide, and d-sotalol.
    Wijffels MC; Dorland R; Allessie MA
    J Cardiovasc Electrophysiol; 1999 Feb; 10(2):178-93. PubMed ID: 10090222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cibenzoline attenuates upregulation of Kv1.5 channel gene expression by experimental paroxysmal atrial fibrillation.
    Yamashita T; Sekiguchi A; Iwasaki YK; Sagara K; Hatano S; Iinuma H; Aizawa T; Fu LT
    Int Heart J; 2005 Mar; 46(2):279-88. PubMed ID: 15876811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spatial correlation analysis of the pharmacological conversion of sustained atrial fibrillation in conscious goats by cibenzoline.
    Hoekstra BP; Diks CG; Allessie MA; DeGoede J
    Arch Physiol Biochem; 2000 Oct; 108(4):332-48. PubMed ID: 11094385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized comparison of flecainide and cibenzoline in the conversion of atrial fibrillation.
    Kühlkamp V; Schmid F; Risler T; Seipel L
    Int J Cardiol; 1991 Apr; 31(1):65-9. PubMed ID: 1906432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Electrophysiologic study of cibenzoline in patients with paroxysmal atrial fibrillation with special reference to atrial fibrillation threshold].
    Inoue D; Ishibashi K; Sakai R; Inoue M; Omori I; Asayama J; Nakagawa M
    Kokyu To Junkan; 1992 Dec; 40(12):1203-8. PubMed ID: 1480832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy of cibenzoline in a case of atrial fibrillation due to cardiac thyrotoxicosis].
    Niakara A; Nébié LV; Samadoulougou AK; Kaboré NJ; Ouandaogo BJ; Drabo YJ
    Ann Cardiol Angeiol (Paris); 1999 Feb; 48(2):113-7; discussion 118. PubMed ID: 12555335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous cibenzoline in the management of acute supraventricular tachyarrhythmias.
    Bru P; Cointe R; Paganelli F; Ricard P; Lévy S
    Cardiovasc Drugs Ther; 1995 Feb; 9(1):85-8. PubMed ID: 7786839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for a class 4 effect of cibenzoline "in vivo".
    Sassine A; Massé C; Brugada J; Romero-Ayala LC; Canovas M; Cazes M; Puech P
    Arch Int Pharmacodyn Ther; 1987 May; 287(1):78-88. PubMed ID: 3632139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spatial correlation analysis of atrial activation patterns during sustained atrial fibrillation in conscious goats.
    Hoekstra BP; Diks CG; Allessie MA; DeGoede J
    Arch Physiol Biochem; 2000 Oct; 108(4):313-31. PubMed ID: 11094384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of the efficacies of disopyramide, cibenzoline and aprindine for the termination of paroxysmal and persistent atrial fibrillation in elderly and non-elderly patients].
    Komatsu T; Nakamura S; Suzuki O; Yomogida K; Horiuchi D; Abe N; Kameda K; Owada S; Tomita H; Oikawa K; Okumura K
    J Cardiol; 2003 Apr; 41(4):191-8. PubMed ID: 12728540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cibenzoline versus propafenone by the oral route for preventing recurrence of atrial arrhythmia: multicenter, randomized, double-blind study].
    Lardoux H; Maison Blanche P; Marchand X; Canler A; Rouesnel P; Bleinc D; Péraudeau P; Scheck F
    Ann Cardiol Angeiol (Paris); 1996 Oct; 45(8):469-79. PubMed ID: 8952741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Injectable and oral cibenzoline in the treatment of supraventricular tachycardia related to intranodal reentry or accessory atrioventricular conduction pathway].
    Fauchier JP; Rouesnel P; Breuillac JC; Cosnay P; Scheck F; Garnier LF
    Ann Cardiol Angeiol (Paris); 1994 Apr; 43(4):194-203. PubMed ID: 8024234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.